![Adi Mor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 1 M $ al 31/05/2026
Adi Mor is the founder of Chemomab Therapeutics Ltd. since 2011, holding the title of CEO, Director & Chief Scientific Officer since 2023.
Dr. Mor was the founder of Chemomab Ltd. since 2011, holding the title of Director, Chief Executive & Scientific Officer from 2011 to 2021.
Dr. Mor holds a doctorate from Tel-Aviv University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 18/03/2026 | 10.346.160 ( 2,5 % ) | 1 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Director Ejecutivo | 01/06/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
Chemomab Ltd.
 Chemomab Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotechnology company that develops therapeutics for fibro-inflammatory diseases | Director Ejecutivo | 16/03/2021 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chemomab Ltd.
Chemomab Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotechnology company that develops therapeutics for fibro-inflammatory diseases | Commercial Services |
Chemomab Therapeutics Ltd.
 Chemomab Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotech company | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
